Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2009

Mar 3, 2009

29831_dirs_2009-03-02_a69760fe-9206-4b91-a158-b0442faccc08.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2009-02-26

Reporting Person: SCHULMAN AMY W (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-02-26 Common Stock A 33911 Acquired 140685.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-02-26 Stock Appreciation Rights $12.70 A 111940 Acquired 2014-02-26 Common Stock (111940.00) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 432.00 Indirect
Common Stock 300.00 Indirect

Footnotes

F1: The reported transaction constitutes the grant of restricted stock units.

F2: I hereby disclaim beneficial ownership of all shares held by members of my family.

F3: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant